Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer

Conditions:   Locally Advanced Pancreatic Adenocarcinoma;   Chemotherapy Effect;   Borderline Resectable Pancreatic Adenocarcinoma;   Pancreatectomy Intervention:   Drug: Folfirinox Sponsors:   Oslo University Hospital;   Haukeland University Hospital;   St. Olavs Hospital;   University Hospital of North Norway;   Helse Stavanger HF Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials